Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Darlow

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Paediatric Drugs|August 26, 2021
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant BacteriaChristopher A Darlow, Renata M A da Costa, Sally Ellis, et al.
Mbio|January 18, 2024
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by <i>Pseudomonas aeruginosa</i>Nicola Farrington, Vineet Dubey, Adam Johnson, et al.
The Journal of Antimicrobial Chemotherapy|September 24, 2025
Antagonistic interaction between posaconazole and olorofim in a murine model of invasive pulmonary aspergillosisChristopher A Darlow, Nicola Farrington, Anne-Grete Märtson, et al.
Nature Microbiology|April 9, 2025
Author Correction: Combining antibiotics to tackle antimicrobial resistanceWilliam Hope, Sumathi Nambiar, Seamus O'Brien, et al.
Nature Microbiology|March 27, 2025
Combining antibiotics to tackle antimicrobial resistanceWilliam Hope, Sumathi Nambiar, Seamus O'Brien, et al.
The Journal of Antimicrobial Chemotherapy|February 16, 2022
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistanceChristopher A Darlow, Nicola Farrington, Adam Johnson, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2022
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settingsChristopher A Darlow, Laura McEntee, Adam Johnson, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial ResistanceChristopher A Darlow, Fernando Docobo-Perez, Nicola Farrington, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Paediatric Drugs|August 26, 2021
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant BacteriaChristopher A Darlow, Renata M A da Costa, Sally Ellis, et al.
Mbio|January 18, 2024
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by <i>Pseudomonas aeruginosa</i>Nicola Farrington, Vineet Dubey, Adam Johnson, et al.
The Journal of Antimicrobial Chemotherapy|September 24, 2025
Antagonistic interaction between posaconazole and olorofim in a murine model of invasive pulmonary aspergillosisChristopher A Darlow, Nicola Farrington, Anne-Grete Märtson, et al.
Nature Microbiology|April 9, 2025
Author Correction: Combining antibiotics to tackle antimicrobial resistanceWilliam Hope, Sumathi Nambiar, Seamus O'Brien, et al.
Nature Microbiology|March 27, 2025
Combining antibiotics to tackle antimicrobial resistanceWilliam Hope, Sumathi Nambiar, Seamus O'Brien, et al.
The Journal of Antimicrobial Chemotherapy|February 16, 2022
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistanceChristopher A Darlow, Nicola Farrington, Adam Johnson, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2022
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settingsChristopher A Darlow, Laura McEntee, Adam Johnson, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial ResistanceChristopher A Darlow, Fernando Docobo-Perez, Nicola Farrington, et al.
Pageof 2